Traders Watching VIVUS (VVUS) and Other Obesity Drug Makers Ahead of Today's CV Panel (OREX) (ARNA)
Tweet Send to a Friend
Get Alerts VVUS Hot Sheet
Trade VVUS Now!
The volatility in obesity drug makers is expected to continue as the FDA's 2-day CV study requirement panel starts today. Briefing documents were posted on March 26.
While VIVUS' (Nasdaq: VVUS) Qnexa received backing from an FDA panel on February 22, there is concerns about a 2-stage pre-approval CV study. Another alternative would be a post-approval CV study, or best case no study at all.
While VIVUS is currently seen in the lead to get their obesity drug to market, Orexigen Therapeutics' (NASDAQ: OREX) Contrave could still beat it to the market if a CV study is required.
In addition to VIVUS and Orexigen, Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) has an obesity treatment. However, its shares were downgraded earlier today.
The scheduled Prescription Drug User Fee Act (PDUFA) date for Qnexa is April 17, 2012.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
While VIVUS' (Nasdaq: VVUS) Qnexa received backing from an FDA panel on February 22, there is concerns about a 2-stage pre-approval CV study. Another alternative would be a post-approval CV study, or best case no study at all.
While VIVUS is currently seen in the lead to get their obesity drug to market, Orexigen Therapeutics' (NASDAQ: OREX) Contrave could still beat it to the market if a CV study is required.
In addition to VIVUS and Orexigen, Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) has an obesity treatment. However, its shares were downgraded earlier today.
The scheduled Prescription Drug User Fee Act (PDUFA) date for Qnexa is April 17, 2012.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Fannie Mae, Freddie Mac Surge as Seriously Delinquent Rate Falls Below 3%
- Highway Holdings (HIHO) Halted Again on Circuit Breaker; Last Up 80%
- InterOil (IOC) Gives Up Gains
Create E-mail Alert Related Categories
FDA, Momentum Movers, Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
